This inventor holds 1 USPTO granted patent. Top assignee: Nutcracker Therapeutics, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Colin Mckinlay: Innovator in mRNA Treatment Nanoparticles
Introduction
Colin Mckinlay is a prominent inventor based in Emeryville, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of mRNA treatment nanoparticles. His innovative work is paving the way for advancements in medical treatments.
Latest Patents
Colin Mckinlay holds a patent for mRNA treatment nanoparticles. This patent represents a crucial step in the evolution of therapeutic technologies aimed at improving patient outcomes.
Career Highlights
Colin Mckinlay is currently associated with Nutcracker Therapeutics, Inc. His role at the company allows him to leverage his expertise in nanotechnology and mRNA applications to drive forward-thinking solutions in healthcare.
Collaborations
Due to space constraints, the collaborations section will be omitted.
Conclusion
Colin Mckinlay's work in mRNA treatment nanoparticles exemplifies the innovative spirit of modern biotechnology. His contributions are essential for the future of medical therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile